A066700 Stock Overview
Engages in the research and development, production, and sale of pharmaceutical products in Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Theragen Etex Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩3,090.00 |
| 52 Week High | ₩4,900.00 |
| 52 Week Low | ₩2,760.00 |
| Beta | 0.33 |
| 1 Month Change | -8.98% |
| 3 Month Change | -12.84% |
| 1 Year Change | -28.14% |
| 3 Year Change | -52.02% |
| 5 Year Change | -62.18% |
| Change since IPO | -49.92% |
Recent News & Updates
Why Theragen EtexLtd's (KOSDAQ:066700) Earnings Are Weaker Than They Seem
Nov 26
Lacklustre Performance Is Driving Theragen Etex Co.,Ltd.'s (KOSDAQ:066700) Low P/E
Oct 17Estimating The Fair Value Of Theragen Etex Co.,Ltd. (KOSDAQ:066700)
Aug 07Recent updates
Why Theragen EtexLtd's (KOSDAQ:066700) Earnings Are Weaker Than They Seem
Nov 26Lacklustre Performance Is Driving Theragen Etex Co.,Ltd.'s (KOSDAQ:066700) Low P/E
Oct 17Estimating The Fair Value Of Theragen Etex Co.,Ltd. (KOSDAQ:066700)
Aug 07Theragen EtexLtd's (KOSDAQ:066700) Solid Profits Have Weak Fundamentals
Mar 27Calculating The Intrinsic Value Of Theragen Etex Co.,Ltd. (KOSDAQ:066700)
Mar 21Is Theragen EtexLtd (KOSDAQ:066700) A Risky Investment?
Feb 11
Did Theragen EtexLtd's (KOSDAQ:066700) Share Price Deserve to Gain 36%?
Jan 16A Look At The Intrinsic Value Of Theragen Etex Co.,Ltd. (KOSDAQ:066700)
Dec 21We're Not So Sure You Should Rely on Theragen EtexLtd's (KOSDAQ:066700) Statutory Earnings
Nov 23Shareholder Returns
| A066700 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -6.2% | -1.7% | -3.7% |
| 1Y | -28.1% | 0.1% | -10.4% |
Return vs Industry: A066700 underperformed the KR Pharmaceuticals industry which returned 0.1% over the past year.
Return vs Market: A066700 underperformed the KR Market which returned -10.4% over the past year.
Price Volatility
| A066700 volatility | |
|---|---|
| A066700 Average Weekly Movement | 5.0% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.7% |
| 10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A066700 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A066700's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 202 | Jin-Yeob Go | www.theragenetex.com |
Theragen Etex Co.,Ltd., together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical products in Korea. It offers drugs in the fields of circulatory, respiratory, digestive, antibiotics, antifungals, analgesic, endocrine and metabolic, hepatoprotective, psychotropic, urinary system, skeletal muscle, PMS, anthelmintic, nutrition, and others. The company was formerly known as Theragen Co., Ltd.
Theragen Etex Co.,Ltd. Fundamentals Summary
| A066700 fundamental statistics | |
|---|---|
| Market cap | ₩98.90b |
| Earnings (TTM) | ₩26.85b |
| Revenue (TTM) | ₩250.00b |
3.7x
P/E Ratio0.4x
P/S RatioIs A066700 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A066700 income statement (TTM) | |
|---|---|
| Revenue | ₩250.00b |
| Cost of Revenue | ₩126.55b |
| Gross Profit | ₩123.46b |
| Other Expenses | ₩96.61b |
| Earnings | ₩26.85b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 838.95 |
| Gross Margin | 49.38% |
| Net Profit Margin | 10.74% |
| Debt/Equity Ratio | 26.7% |
How did A066700 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 05:41 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Theragen Etex Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|